• Exchange: OTC US
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Medical Equipment

ULGX:US

0.1500 USD 0.00000.00%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Urologix Inc (ULGX)

Open: 0.1520 Day's Range: 0.1301 - 0.1590 Volume: 73,419
Previous Close: 0.1500 52wk Range: 0.1054 - 0.5325 1-Yr Rtn: -65.52%

Stock Chart for ULGX

No chart data available.
  • ULGX:US 0.1500
  • 1D
  • 1M
  • 1Y
0.1500
Interactive ULGX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ULGX

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.2400
Est. EPS (USD) (06/2014) -
Est. PEG Ratio -
Market Cap (M USD) 3.20
Shares Outstanding (M) 21.33
30 Day Average Volume 28,272
Price/Book (mrq) -
Price/Sale (ttm) 0.1989
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ULGX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ULGX

Urologix, Inc. develops, manufactures, and markets minimally invasive medical products for the treatment of urological disorders. The Company's Targis System is a non-surgical, anesthesia-free, catheter-based therapy that uses a proprietary microwave technology for the treatment of benign prostatic hyperplasia.

Gregory J Fluet "Greg"Chief Executive OfficerBrian J SmrdelChief Financial Officer
Lisa AckermanExec VP:Sales & Marketing
More Company Profile & Key Executives for ULGX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil